Health ❯Healthcare ❯Clinical Trials ❯Patient Outcomes
Analysis of nationwide registry data from 2015 to 2023 shows that prior PSMA PET/CT raises long-term survival, prompting calls for earlier use of molecular imaging in prostate cancer care.